S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
$0.11
+12.8%
$0.15
$0.08
$0.24
$25.23M3.4772,260 shs16,407 shs
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
$0.11
+10.0%
$0.15
$0.16
$4.69
$22.35M5.57250,570 shs84,688 shs
Cyanotech Co. stock logo
CYAN
Cyanotech
$0.33
$3.01
$2.37
$6.29
$2.29M0.285,029 shs1 shs
Glucose Health, Inc. stock logo
GLUC
Glucose Health
$0.50
$0.69
$0.09
$0.90
$8.52M3.427,942 shs104,695 shs
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
$0.00
$0.00
$0.00
$710K0.1430,002 shsN/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
+12.82%+1.29%-28.06%-42.41%+10.55%
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
+3.17%-11.28%-36.21%-48.95%-2.60%
Cyanotech Co. stock logo
CYAN
Cyanotech
0.00%-4.35%+13.60%-62.98%-67.00%
Glucose Health, Inc. stock logo
GLUC
Glucose Health
-0.70%-4.02%-29.63%+99.44%+6.30%
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
N/AN/AN/AN/AN/AN/AN/AN/A
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
N/AN/AN/AN/AN/AN/AN/AN/A
Cyanotech Co. stock logo
CYAN
Cyanotech
N/AN/AN/AN/AN/AN/AN/AN/A
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/AN/AN/AN/AN/AN/AN/AN/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
N/AN/AN/AN/A
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
N/AN/AN/AN/A
Cyanotech Co. stock logo
CYAN
Cyanotech
N/AN/AN/AN/A
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/AN/AN/AN/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
$16.25M1.55N/AN/A$0.01 per share11.00
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
$16.69M1.34N/AN/A($0.03) per share-3.67
Cyanotech Co. stock logo
CYAN
Cyanotech
$23.18M0.10N/AN/A$2.61 per share0.13
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/AN/AN/AN/AN/AN/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
$100K0.00N/AN/AN/ANaN

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
-$1.59M-$0.01N/AN/A-26.06%-711.61%-63.52%N/A
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
-$7.19MN/A0.00N/A-140.60%N/A-327.67%N/A
Cyanotech Co. stock logo
CYAN
Cyanotech
-$3.44M-$0.74N/AN/A-20.52%-30.97%-16.17%6/25/2024 (Estimated)
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/AN/A0.00N/AN/AN/AN/AN/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
-$13.10MN/A0.00N/AN/AN/AN/AN/AN/A

Latest CYAN, NPHC, GLUC, CHUCD, and CHUC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/8/2024Q3 2024
Cyanotech Co. stock logo
CYAN
Cyanotech
N/A-$0.16-$0.16-$0.16N/A$5.58 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
N/AN/AN/AN/AN/A
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
N/AN/AN/AN/AN/A
Cyanotech Co. stock logo
CYAN
Cyanotech
N/AN/AN/AN/AN/A
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/AN/AN/AN/AN/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
N/A
1.02
0.36
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
N/A
0.22
0.17
Cyanotech Co. stock logo
CYAN
Cyanotech
0.07
1.44
0.37
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/AN/AN/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
7.80%
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
3.11%
Cyanotech Co. stock logo
CYAN
Cyanotech
24.40%
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
N/A

Insider Ownership

CompanyInsider Ownership
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
22.50%
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
74.80%
Cyanotech Co. stock logo
CYAN
Cyanotech
25.20%
Glucose Health, Inc. stock logo
GLUC
Glucose Health
N/A
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
61.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Charlie's Holdings, Inc. stock logo
CHUC
Charlie's
35229.35 million177.75 millionNot Optionable
Charlie's Holdings, Inc. stock logo
CHUCD
Charlie's
45203.17 millionN/ANot Optionable
Cyanotech Co. stock logo
CYAN
Cyanotech
956.95 million5.20 millionNot Optionable
Glucose Health, Inc. stock logo
GLUC
Glucose Health
147,00017.06 millionN/ANot Optionable
Nutra Pharma Corp. stock logo
NPHC
Nutra Pharma
47.06 billion2.72 billionNot Optionable

CYAN, NPHC, GLUC, CHUCD, and CHUC Headlines

SourceHeadline
FitLife Brands (NASDAQ:FTLF) and Nutra Pharma (OTCMKTS:NPHC) Head-To-Head AnalysisFitLife Brands (NASDAQ:FTLF) and Nutra Pharma (OTCMKTS:NPHC) Head-To-Head Analysis
americanbankingnews.com - April 10 at 1:42 AM
Biscuit brand Britannia forays into healthtech with NutriPlus appBiscuit brand Britannia forays into healthtech with NutriPlus app
msn.com - April 3 at 2:29 PM
Nutra Pharma Corp. Reaches Settlement with SECNutra Pharma Corp. Reaches Settlement with SEC
prismmediawire.com - March 22 at 4:40 PM
Nutra Pharma Corp. Reaches Settlement with SECNutra Pharma Corp. Reaches Settlement with SEC
globenewswire.com - March 22 at 4:39 PM
Collegium PharmaceuticalCollegium Pharmaceutical
forbes.com - March 3 at 12:29 PM
FAO report says over-fishing putting sea cucumbers at riskFAO report says over-fishing putting sea cucumbers at risk
en.mercopress.com - February 22 at 7:14 PM
Nutra Pharma Corp.Nutra Pharma Corp.
wsj.com - February 21 at 12:18 PM
Nutri Pharmaceuticals Research Inc.Nutri Pharmaceuticals Research Inc.
barrons.com - October 7 at 8:52 PM
Pharma companies with more than Rs 250 crores turnover to be given 6 months to adopt Good Manufacturing Practices: Official sourcesPharma companies with more than Rs 250 crores turnover to be given 6 months to adopt Good Manufacturing Practices: Official sources
health.economictimes.indiatimes.com - August 24 at 1:24 AM
New products, nutraceuticals added under Jan Aushadhi PariyojanaNew products, nutraceuticals added under Jan Aushadhi Pariyojana
medicaldialogues.in - July 30 at 10:49 AM
L-Nutra Reports First-Ever Study Showing ProLon® Improves Skin Health, Happiness, and ConfidenceL-Nutra Reports First-Ever Study Showing ProLon® Improves Skin Health, Happiness, and Confidence
benzinga.com - March 1 at 9:21 PM
The best nutri-boost supplements for your pupThe best nutri-boost supplements for your pup
hindustantimes.com - November 15 at 6:59 PM
Nutra Pharma Corp. priceNutra Pharma Corp. price
seekingalpha.com - September 16 at 9:25 AM
Active Health Foods (AHFD)Active Health Foods (AHFD)
investing.com - September 1 at 10:57 PM
Medixall Group Inc (MDXL)Medixall Group Inc (MDXL)
investing.com - August 31 at 9:55 PM
PharmaNutra buys AkernPharmaNutra buys Akern
poandpo.com - June 17 at 3:30 PM
Nutra Pharma signs first manufacturing agreementNutra Pharma signs first manufacturing agreement
seekingalpha.com - March 23 at 4:30 PM
Nutra Pharma Announces First Manufacturing AgreementNutra Pharma Announces First Manufacturing Agreement
finance.yahoo.com - March 23 at 4:30 PM
Nutra Pharma Expands Manufacturing CapabilitiesNutra Pharma Expands Manufacturing Capabilities
finance.yahoo.com - March 17 at 7:37 PM
Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter MeasuresNutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures
finance.yahoo.com - July 23 at 9:22 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Charlie

Charlie's

OTCMKTS:CHUC
Charlie's Holdings, Inc., together with its subsidiaries, formulates, markets, and distributes nicotine-based vapor products in the United States and internationally. The company also provides non-combustible nicotine-related, alternative alkaloid vapor products, and hemp-derived vapor and edible products. It sells its products through distributors, specialty retailers, and third-party online resellers to approximately 80 countries, primarily, including the United Kingdom, Italy, Spain, New Zealand, Australia, and Canada. The company was formerly known as True Drinks Holdings, Inc. Charlie's Holdings, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.
Charlie

Charlie's

OTCMKTS:CHUCD
Charlie's Holdings, Inc., together with its subsidiaries, formulates, markets, and distributes e-cigarette liquids and vaping systems in the United States and internationally. The company also offers energy drink under the Bazi brand name. It sells its products through distributors, specialty retailers, and third-party online resellers to approximately 80 countries, primarily, including the United Kingdom, Italy, Spain, Belgium, Australia, Sweden, and Canada. The company was formerly known as True Drinks Holdings, Inc. and changed its name to Charlie's Holdings, Inc. Charlie's Holdings, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.
Cyanotech logo

Cyanotech

NASDAQ:CYAN
Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
Glucose Health logo

Glucose Health

OTCMKTS:GLUC
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
Nutra Pharma logo

Nutra Pharma

OTCMKTS:NPHC
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated with arthritis and repetitive stress; Pet Pain-Away, a homeopathic, nonnarcotic, nonaddictive, and overthecounter pain reliever to treat chronic pain in companion animals; Luxury Feet, an over-the-counter pain reliever and antiinflammatory product to treat pain or discomfort due to high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Pain-Away, an over-the-counter topical pain reliever to relieve pain in horses. It is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, as well as for general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Plantation, Florida.